Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACHE | P22303 | 2/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | BPTF | Q12830 | 1/20 | 0.36 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.33 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.32 |
| ▸ | HTT | P42858 | 1/20 | 0.32 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.31 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.31 |
| ▸ | USP2 | O75604 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22020038 | 0.76 | ACHE (0.62) | ACHEMEN1MAPK1KMT2ABPTF | |
| SCHEMBL22019941 | 0.73 | USP2 (0.37) | ACHEMEN1MAPK1KMT2ABPTF | |
| SCHEMBL19272311 | 0.60 | ACHE (0.54) | ACHEMEN1MAPK1KMT2ABPTF | |
| SCHEMBL22021532 | 0.59 | ACHE (0.58) | ACHEMEN1MAPK1KMT2ABPTF | |
| SCHEMBL12507661 | 0.56 | ACHE (0.56) | ACHEMEN1MAPK1KMT2ABPTF | |
| SCHEMBL20681035 | 0.56 | ACHE (0.95) | ACHEMEN1MAPK1KMT2ABPTF | |
| SCHEMBL21963258 | 0.56 | ACHE (0.54) | ACHEMEN1MAPK1KMT2ABPTF | |
| SCHEMBL20761734 | 0.56 | ACHE (0.54) | ACHEMEN1MAPK1KMT2ABPTF | |
| SCHEMBL31138748 | 0.56 | ALDH1A1 (0.33) | ALDH1A1HTT | |
| SCHEMBL22020517 | 0.56 | ACHE (0.48) | ACHEMEN1MAPK1KMT2ABPTF |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2020102096-A1 | COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH NLRP ACTIVITY | NOVARTIS INFLAMMASOME RESEARCH, INC. (US) | 2020-05-22 | — | — | WO | disclosed |